FEDERAL · 21 U.S.C. · Chapter SUBCHAPTER X—MISCELLANEOUS
Practice of medicine
21 U.S.C. § 396
Title21 — Food and Drugs
ChapterSUBCHAPTER X—MISCELLANEOUS
This text of 21 U.S.C. § 396 (Practice of medicine) is published on Counsel Stack Legal Research, covering United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
21 U.S.C. § 396.
Text
Nothing in this chapter shall be construed to limit or interfere with the authority of a health care practitioner to prescribe or administer any legally marketed device to a patient for any condition or disease within a legitimate health care practitioner-patient relationship. This section shall not limit any existing authority of the Secretary to establish and enforce restrictions on the sale or distribution, or in the labeling, of a device that are part of a determination of substantial equivalence, established as a condition of approval, or promulgated through regulations. Further, this section shall not change any existing prohibition on the promotion of unapproved uses of legally marketed devices.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Buckman Co. v. Plaintiffs' Legal Committee
531 U.S. 341 (Supreme Court, 2001)
Riley v. Cordis Corp.
625 F. Supp. 2d 769 (D. Minnesota, 2009)
United States v. Solvay Pharmaceuticals, Inc.
871 F.3d 318 (Fifth Circuit, 2017)
United States v. Caronia
703 F.3d 149 (Second Circuit, 2012)
Caplinger v. Medtronic, Inc.
784 F.3d 1335 (Tenth Circuit, 2015)
Ramirez v. Medtronic Inc.
961 F. Supp. 2d 977 (D. Arizona, 2013)
United States ex rel. Modglin v. DJO Global Inc.
48 F. Supp. 3d 1362 (C.D. California, 2014)
Sita v. Danek Medical, Inc.
43 F. Supp. 2d 245 (E.D. New York, 1999)
UFCW Local 1776 & Participating Employers Health & Welfare Fund v. Eli Lilly & Co.
253 F.R.D. 69 (E.D. New York, 2008)
Davenport v. Medtronic, Inc.
302 F. Supp. 2d 419 (E.D. Pennsylvania, 2004)
Aaron v. Medtronic, Inc.
209 F. Supp. 3d 994 (S.D. Ohio, 2016)
Nightingale Home Healthcare, Inc. v. Anodyne Therapy, LLC
626 F.3d 958 (Seventh Circuit, 2010)
Southard v. Temple University Hospital
731 A.2d 603 (Superior Court of Pennsylvania, 1999)
United States ex rel. Polansky v. Pfizer, Inc.
822 F.3d 613 (Second Circuit, 2016)
Southard v. Temple University Hospital
781 A.2d 101 (Supreme Court of Pennsylvania, 2001)
Knipe v. Smithkline Beecham
583 F. Supp. 2d 602 (E.D. Pennsylvania, 2008)
Healey v. I-Flow, LLC
853 F. Supp. 2d 868 (D. Minnesota, 2012)
McCormick v. Medtronic, Inc.
101 A.3d 467 (Court of Special Appeals of Maryland, 2014)
Scovil v. Medtronic, Inc.
995 F. Supp. 2d 1082 (D. Arizona, 2014)
Martin v. Medtronic, Inc.
32 F. Supp. 3d 1026 (D. Arizona, 2014)
Source Credit
History
(June 25, 1938, ch. 675, §1006, formerly §906, as added Pub. L. 105–115, title II, §214, Nov. 21, 1997, 111 Stat. 2348; renumbered §1006, Pub. L. 111–31, div. A, title I, §101(b)(2), June 22, 2009, 123 Stat. 1784.)
Editorial Notes
Statutory Notes and Related Subsidiaries
Effective Date
Section effective 90 days after Nov. 21, 1997, except as otherwise provided, see section 501 of Pub. L. 105–115, set out as an Effective Date of 1997 Amendment note under section 321 of this title.
Effective Date
Section effective 90 days after Nov. 21, 1997, except as otherwise provided, see section 501 of Pub. L. 105–115, set out as an Effective Date of 1997 Amendment note under section 321 of this title.
Cite This Page — Counsel Stack
Bluebook (online)
21 U.S.C. § 396, Counsel Stack Legal Research, https://law.counselstack.com/usc/21/396.